Oracle has agreed to leverage its Health Science division’s Clinical One platform to combine clinical trial operations of Servier, providing a next-generation trial management setting.
Performance and management of trials is a long, structured process and involves large amounts of data that must be shared with several stakeholders, Oracle noted.
Servier aims to digitise and standardise its overall clinical trials approach.
The company performed a detailed review process and selected Oracle’s platform, which adopts a data-based technique that can support Servier’s plan for a unified and modern trial environment.
Servier Group Clinical Development head and R&D CMO Patricia Belissa-Mathiot said: “All of our processes, from study startup through conduct and close out, will be integrated and streamlined on the Oracle Clinical One platform.
“Our teams will now be able to follow, analyse data and draw valuable clinical insight, in a single place, which will ultimately help accelerate bringing our therapies to market to patients waiting in need.”
With its presence in 150 countries, Servier focuses on oncology, cardiovascular and metabolic diseases, immuno-inflammatory, and neurodegenerative disorders.
Oracle Health Science’s Clinical One platform will merge Servier’s clinical environment to commence new trials more efficiently.
The platform will also enable real-time mid-study changes and unify everyone associated with a trial, including clinical research organisations and sponsors, in a single data setting.
Oracle Health Sciences senior vice-president and general manager Henry McNamara said: “With our Clinical One platform and solutions, Servier can create a technological environment that further enables it to fuel breakthrough, life-saving discoveries.
“Our unified approach to clinical trials will set Servier apart today and in the future, as the industry continues to transform how it conducts clinical trials.”
Clinical One can reduce weeks of standard clinical operations, according to Oracle.
The platform can also facilitate business efficacies throughout the trial lifecycle such as trial budgeting and prediction, site selection and activation, randomisation, and trial supply, among other capabilities.
Apart from addressing different decentralised trial features, the platform allows data gathering from new and various data sources, coordinating the data and avoiding reconciliation.
Servier is also using Oracle Argus for processing its safety cases.
Earlier this year, Oracle and Saama Technologies collaborated to accelerate clinical trials.